21-Jul-2026
Download PDF
Glaxosmithkline Pharma
Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
